Advocacy intelligence hub — real-time data for patient organizations
Sutro Biopharma, Inc. — PHASE1
GI Innovation, Inc. — PHASE1, PHASE2
ImmunoGenesis — PHASE1, PHASE2
University of Washington — NA
Taiho Oncology, Inc. — PHASE2
Oncolytics Biotech — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Alimta
(pemetrexed disodium)Orphan drugstandardEli Lilly and Company
12.1 Mechanism of Action ALIMTA is a folate analog metabolic inhibitor that disrupts folate-dependent metabolic processes essential for cell replicati...
Anthony El-Khoueiry, M.D
SWOG Cancer Research Network
📍 LOS ANGELES, CA
Vincent Chung, MD
City of Hope Medical Center
📍 DUARTE, CA
Study Official
Genmab
Liu Yang, M.D.
Zhejiang Provincial People's Hospital
Nina Merchant
Medicenna Therapeutics
Jyotsna Fuloria, MD
Fuloria Clinical Research Solutions LLC
📍 ATLANTA, GA